or Try an Advanced Search...

    Technical Analysis for KTTA - Pasithea Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 6.60 1.54% 0.10
    KTTA closed up 1.54 percent on Friday, May 17, 2024, on 25 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical KTTA trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    BB Squeeze Ended Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction 1.54%
    Narrow Range Bar Range Contraction 1.54%
    Oversold Stochastic Weakness 1.54%
    Bollinger Band Squeeze Range Contraction -0.75%
    Stochastic Reached Oversold Weakness -0.75%
    Older End-of-Day Signals for KTTA ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 3 days ago
    Up 1% 3 days ago
    Down 2 % 4 days ago
    60 Minute Opening Range Breakdown 4 days ago
    3x Volume Pace 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    KTTA Chart by TradingView
    Basic chart:

    Profile

    Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Drugs Pharmacy Psychoactive Drugs Neurochemistry Antidepressants Ketones Sedatives Psychiatric And Neurological Disorders Business Support Services

    Is KTTA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 29 Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
    Apr 24 Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers
    Feb 13 Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
    Jan 8 Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position
    Jan 2 Pasithea conducts 1-for-20 reverse stock split, gets FDA okay for study
    Jan 2 Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients
    Dec 28 Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
    Dec 19 Pasithea Therapeutics Announces Results from 2023 Annual Meeting
    Dec 11 Pasithea stock soars as high as 190% on preclinical data
    Dec 11 Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models
    See more KTTA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.4
    52 Week Low 5.254
    Average Volume 1,822
    200-Day Moving Average 8.12
    50-Day Moving Average 7.26
    20-Day Moving Average 7.02
    10-Day Moving Average 7.00
    Average True Range 0.29
    RSI (14) 40.83
    ADX 14.15
    +DI 30.77
    -DI 41.03
    Chandelier Exit (Long, 3 ATRs) 6.83
    Chandelier Exit (Short, 3 ATRs) 7.36
    Upper Bollinger Bands 7.62
    Lower Bollinger Band 6.41
    Percent B (%b) 0.16
    BandWidth 17.33
    MACD Line -0.17
    MACD Signal Line -0.11
    MACD Histogram -0.061
    Fundamentals Value
    Market Cap 6.88 Million
    Num Shares 1.04 Million
    EPS -13.00
    Price-to-Earnings (P/E) Ratio -0.51
    Price-to-Sales 12.95
    Price-to-Book 0.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.60
    Resistance 3 (R3) 6.60 6.60 6.60
    Resistance 2 (R2) 6.60 6.60 6.60 6.60
    Resistance 1 (R1) 6.60 6.60 6.60 6.60 6.60
    Pivot Point 6.60 6.60 6.60 6.60 6.60
    Support 1 (S1) 6.60 6.60 6.60 6.60 6.60
    Support 2 (S2) 6.60 6.60 6.60 6.60
    Support 3 (S3) 6.60 6.60 6.60
    Support 4 (S4) 6.60